MedTrace Logo

Bioimpedance-guided Fluid Management in Chronic Peritoneal Dialysis Patients.

NCT03004963 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 213

Last updated 2024-11-22

No results posted yet for this study

Summary

Peritoneal dialysis (PD) is one of established treatments in the end stage renal disease patients. Volume overload is a predictor of mortality in PD patients. In this Randomized controlled trial, the investigators use the Body Composition Monitor (BCM), a multifrequency bioimpedance device, to measure the level of overhydration in PD patients and explore its value in fluid management in peritoneal dialysis patients as well as their prognosis.

Conditions

Interventions

DEVICE

Body composition monitor

Both body composition monitor (BCM) is used to evaluate the volume status of patients.

DEVICE

clinical indexes

The investigators evaluate the volume status of patients according to clinical indexes.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Wei Fang, Dr · Department of Nephrology, Renji Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03004963 on ClinicalTrials.gov